Abstract
Oral lichen planus (OLP) is a relatively common, chronic, and inflammatory mucocutaneous disease. Xerostomia is also a common complaint of most OLP patients. Considering the significant role of M3 muscarinic receptors (M3R) in secretion of saliva, this study sought to compare the level of this receptor in saliva between OLP patients and healthy controls. Forty OLP patients and 40 healthy controls filled out two questionnaires regarding xerostomia to assess its degree of severity. Unstimulated and stimulated salivary samples were obtained of both groups and the stimulated and unstimulated salivary flow rates were calculated. Salivary level of M3 muscarinic receptors was measured using the ELISA kit. Data were analyzed and compared using unpaired student’s t test. P < 0.05 was considered significant. Stimulated and unstimulated salivary flow rates and M3 muscarinic receptors levels were significantly lower but degree of xerostomia was significantly higher in OLP patients compared to healthy controls. Salivary M3 muscarinic receptor seems to be low in the patients with OLP and these patients suffer from xerostomia and reduced salivary flow rate.
Similar content being viewed by others
References
Agarwal P (2003) Immunopathogenesis of Sjögren’s syndrome. J Indian Rheumatol Assoc 11(3):71–75
Aghahosseini F, Arbabi-Kalati F, Fashtami LA, Djavid GE, Fateh M, Beitollahi JM (2006) Methylene blue-mediated photodynamic therapy: a possible alternative treatment for oral lichen planus. Med Oral Patol Oral Cir Bucal 11(2):E126–E129
Agha-Hosseini F, Mirzaii-Dizgah I, Abdollahi M, Akbari-Gillani N (2011) Efficacy of IMOD in the treatment of oral lichen planus. Open J Stomatol 1:13
Agha-Hosseini F, Mirzaii-Dizgah I, Farmanbar N, Abdollahi M (2012) Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma. J Oral Pathol Med 41(10):736–740. doi:10.1111/j.1600-0714.2012.01172.x
Agha-Hosseini F, Mirzaii-Dizgah I, Mikaili S, Abdollahi M (2009) Increased salivary lipid peroxidation in human subjects with oral lichen planus. Int J Dent Hyg 7(4):246–250. doi:10.1111/j.1601-5037.2009.00365.x
Agha-Hosseini F, Mirzaii-Dizgah I, Moosavi M-S (2011) Relationship of lumbar spine bone mineral density and oral dryness feeling in menopause. Menopause 18(6):625–628
Agha-Hosseini F, Moosavi MS, Mirzaii-Dizgah I (2013) Salivary flow, testosterone, and femur bone mineral density in menopausal women with oral dryness feeling. Oral Surg Oral Med Oral Pathol Oral Radiol 115(5):612–616. doi:10.1016/j.oooo.2012.11.014
Brand HS, Veerman E (2013) Saliva and wound healing. Chin J Dent Res 16:7–12
Budimir V, Richter I, Andabak-Rogulj A, Vučićević-Boras V, Budimir J, Brailo V (2014) Oral lichen planus—retrospective study of 563 Croatian patients. Med Oral Patol Oral Cir Bucal 19(3):e255–e260
Colquhoun AN, Ferguson MM (2004) An association between oral lichen planus and a persistently dry mouth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98(1):60–68
Dawes C (2004) How much saliva is enough for avoidance of xerostomia? Caries Res 38:236–240
Gorouhi F, Davari P, Fazel N (2014) Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. Sci World J 2014:742826. doi:10.1155/2014/742826
Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T (2010) Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren’s syndrome-like sialoadenitis. J Autoimmun 35(4):383–389. doi:10.1016/j.jaut.2010.08.004
Ito Y, Oyunzul L, Yoshida A, Fujino T, Noguchi Y, Yuyama H, Ohtake A, Suzuki M, Sasamata M, Matsui M, Yamada S (2009) Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice. Eur J Pharmacol 615(1–3):201–206. doi:10.1016/j.ejphar.2009.04.068
Jin M, Hwang SM, Davies AJ, Shin Y, Bae JS, Lee JH, Lee EB, Song YW, Park K (2012) Autoantibodies in primary Sjögren’s syndrome patients induce internalization of muscarinic type 3 receptors. Biochim Biophys Acta 1822(2):161–167. doi:10.1016/j.bbadis.2011.11.012
Kho HS, Chang JY, Kim YY, Kim Y (2013) MUC1 and Toll-like receptor-2 expression in burning mouth syndrome and oral lichen planus. Arch Oral Biol 58(7):837–842. doi:10.1016/j.archoralbio.2013.01.008
Kim N, Shin Y, Choi S, Namkoong E, Kim M, Lee J, Song Y, Park K (2015) Effect of antimuscarinic autoantibodies in primary Sjögren’s syndrome. J Dent Res 94(5):722–728. doi:10.1177/0022034515577813
Kruszka P, O’Brian RJ (2009) Diagnosis and management of Sjögren syndrome. Am Fam Physician 79(6):465–470
López-Jornet P, Parra-Perez F, Pons-Fuster A (2014) Association of autoimmune diseases with oral lichen planus: a cross-sectional, clinical study. J Eur Acad Dermatol Venereol 28(7):895–899. doi:10.1111/jdv.12202
Lundström IM, Anneroth KG, Bergstedt HF (1982) Salivary gland function and changes in patients with oral lichen planus. Scand J Dent Res 90(6):443–458
Nguyen VT, Chernyavsky AI, Arredondo J, Bercovich D, Orr-Urtreger A, Vetter DE, Wess J, Beaudet AL, Kitajima Y, Grando SA (2004) Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res 294(2):534–549
Reina S, Sterin-Borda L, Passafaro D, Borda E (2011) Anti-M(3) muscarinic cholinergic autoantibodies from patients with primary Sjögren’s syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E(2) (PGE(2)) from the submandibular glands. Arch Oral Biol 56(5):413–420. doi:10.1016/j.archoralbio.2010.08.017
Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus—a review. J Oral Pathol Med 39(10):729–734. doi:10.1111/j.1600-0714.2010.00946.x
Ryberg AT, Warfvinge G, Axelsson L, Soukup O, Götrick B, Tobin G (2008) Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man. Arch Oral Biol 53(1):66–74
Shida T, Tokunaga A, Kondo E, Ueda Y, Ohno K, Saika T, Kiyama H, Tohyama M (1993) Expression of muscarinic and nicotinic receptor mRNA in the salivary gland of rats: a study by in situ hybridization histochemistry. Brain Res Mol Brain Res 17(3–4):335–339
Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13(4):350–365
Tobin G, Giglio D, Götrick B (2002) Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats. Auton Neurosci 100(1–2):1–9
Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, Goto D, Ito S, Sumida T (2010) New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren’s syndrome. Clin Exp Immunol 162(1):53–61. doi:10.1111/j.1365-2249.04188.x
van der Meij EH, van der Waal I (2003) Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32(9):507–512
Villa A, Connell CL, Abati S (2014) Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag 11:45–51. doi:10.2147/TCRM.S76282
Yamada S, Maruyama S, Takagi Y, Uchida S, Oki T (2006) In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice. Life Sci 80(2):127–132
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Agha-Hosseini, F., Mirzaii-Dizgah, I. & Mohammadpour, N. Muscarinic cholinergic receptors (MR3) in saliva of patients with oral lichen planus. Arch Dermatol Res 308, 481–486 (2016). https://doi.org/10.1007/s00403-016-1670-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-016-1670-7